KOSPIApparel & Living013890

Zinus

₩6,330▼ 0.16%2026-11-18 close
Market Cap
₩138.8B
Turnover
₩200M
Volume
20K
Shares out.
21.9M
PER
—
PBR
0.3×
EPS
-₩5,767
Dividend Yield
1.43%

PER, EPS, PBR and BPS are calculated in-house from the last 4 quarters (2025Q4–2026Q3) · Dividend yield is based on ₩90 per share · Prices as of the 2026-11-18 close

01

Report overview

Zinus: Plant Sale and Production Restructuring Amid Losses

Zinus has posted operating losses for five straight quarters through Q3 2026 as US sales weakened, and is restructuring around a Georgia plant sale and a shift toward Indonesian and Cambodian production.

  1. 1

    Operating profit turned positive at KRW 25.5 billion in 2025, but the company has recorded operating losses for five consecutive quarters through Q3 2026.

  2. 2

    Q3 2026 sales of KRW 225.2 billion rose 52.7% from the prior quarter but fell 6.8% year on year.

  3. 3

    Media reports say 81.2% of 2025 annual sales came from the United States, underscoring heavy dependence on one market.

  4. 4

    The Georgia plant was sold for KRW 135.3 billion, with proceeds received in early September 2026 and an expected gain of about KRW 31.8 billion reported.

  5. 5

    Net loss attributable to controlling shareholders totaled KRW 126.4 billion over the last four quarters, against total equity of KRW 649.4 billion at end-2025.

02

Business structure

Zinus is a mattress and furniture company that sells bed frames, sofas and other non-mattress products alongside mattresses. Media reports put the Q3 2026 sales mix at 69.6% mattresses and 30.4% non-mattress products, based on the preliminary results announced on November 3, 2026.

The United States is the core market, and media reports say it accounted for 81.2% of 2025 annual sales. US sales in Q3 2026 were KRW 178.0 billion, down 2.7% year on year, per the same preliminary release.

The company sells mainly through US online retail channels such as Amazon, and its US-bound mattresses have been produced largely at the Indonesian plant. Media reports say utilization at the Indonesian plant fell to 51.7% in Q1 2026, while the Cambodian plant rose to 70.4%.

The Georgia plant stopped production in November 2025 and was agreed for sale in May 2026, and media reports say the Chinese and US subsidiaries were liquidated. Hyundai Department Store Group acquired Zinus in 2022 for KRW 879.0 billion, and as of September 2026 Hyundai Department Store held a 38.6% stake.

Competition centers on price, and a 2024 US consumer publication named a Zinus product best value in its mattress category. However, in Q3 2026 mattress sales fell 11.7% while non-mattress sales rose 6.7%, so product diversification has not yet offset the decline in total sales.

03

Earnings trend

Quarterly revenue · Operating profit
RevenueOperating profit
Annual revenue · Operating profit
RevenueOperating profit
Quarterly results · Last 5 quarters
QuarterRevenueOperating profitOp. margin
2025Q3₩241.7B-₩7.6B−3.2%
2025Q4₩192B-₩23.5B−12.2%
2026Q1₩139.6B-₩30.1B−21.6%
2026Q2₩147.5B-₩26.7B−18.1%
2026Q3₩225.2B-₩12.5B−5.5%
Annual results
YearRevenueOperating profitNet income (parent)Op. marginROEDebt-to-equity
2022₩1.2T₩65.6B₩29.4B5.7%4.7%78.0%
2023₩952.3B₩18.3B₩5.3B1.9%0.8%66.4%
2024₩920.4B-₩5.4B-₩6.8B−0.6%−1.0%77.2%
2025₩913.2B₩25.5B-₩18.5B2.8%−2.8%65.3%

Consolidated basis (financial statements including subsidiaries) · Final figures from DART filings · Net income attributable to owners of the parent · Data as of 2026-11-13

04

Earnings analysis

On the basis of the DART-filed figures, annual sales fell from KRW 1.16 trillion in 2022 to KRW 952.3 billion in 2023 (down 17.9% year on year), KRW 920.4 billion in 2024 (down 3.3%) and KRW 913.2 billion in 2025 (down 0.8%), a decline in each of the three years from 2023 to 2025.

The largest sales year in the 2022 to 2025 period was 2022. Operating profit dropped from KRW 65.6 billion in 2022 to KRW 18.3 billion in 2023 (down 72.0%), and the company swung to an operating loss of KRW 5.45 billion in 2024.

It returned to operating profit of KRW 25.5 billion in 2025, with an operating margin of 2.8%. Behind the margin pressure is a fixed-cost burden that does not shrink with volume, since staff and plant upkeep continue even when production falls.

Net profit attributable to controlling shareholders fell from KRW 29.4 billion in 2022 to KRW 5.3 billion in 2023 (down 82.0%), then turned into a net loss of KRW 6.8 billion in 2024 and widened to a net loss of KRW 18.5 billion in 2025.

Operating cash flow was KRW 216.7 billion in 2025, improving from an outflow of KRW 3.9 billion in 2024.

Quarterly sales went from KRW 241.7 billion in Q3 2025 to KRW 192 billion in Q4 2025 (down 20.6% quarter on quarter) and KRW 139.6 billion in Q1 2026 (down 27.3%), then rose to KRW 147.5 billion in Q2 and KRW 225.2 billion in Q3 2026, two consecutive quarterly increases.

Operating losses widened from KRW 7.63 billion in Q3 2025 to KRW 30.1 billion in Q1 2026 before narrowing to KRW 26.7 billion in Q2 and KRW 12.5 billion in Q3.

Q3 2026 selling and administrative expenses were KRW 73.9 billion, up 3.6% year on year, and rose to 32.8% of sales from 29.5% a year earlier, including about KRW 5 billion of one-off severance tied to restructuring, according to media coverage of the November 3, 2026 preliminary release.

The gap between operating and net results in Q3 2026 reflected a foreign currency translation loss of KRW 24.9 billion and deferred tax and other items of KRW 10.1 billion linked to the Georgia plant sale.

05

Industry analysis

The company and media coverage both attribute the US mattress slump to a prolonged decline in consumer sentiment that reduced orders from key customers.

Media reports say US sales in the first half of 2026 fell 48.6% year on year to KRW 191.2 billion, and that a price increase meant to pass through tariff costs led to lower orders. Reports put the US reciprocal tariff on Indonesian-made products at 19%.

Concentrating production in Indonesia has raised concern that tariff shocks will hit harder. Media coverage also described the company's judgment that making products in Indonesia and exporting them to the US is more profitable than US production. Competition centers on price.

In May 2024, a US consumer publication named a Zinus mattress its best value pick, and coverage noted it was about 86% cheaper than the competing product selected as the top mattress in that review. The 2026 price increase, however, runs against that price positioning.

It is difficult to pin down where the category stands in its cycle, so the pace at which customer orders normalize is the practical gauge of demand recovery. The company has said its customers' order volumes are gradually normalizing.

06

Outlook

In its Q3 2026 earnings release, the company said it will keep restructuring production, logistics and other operations to extend the margin improvement into Q4.

In a September 2026 report, the company also said it expects gradual profit improvement from expanded orders from key customers starting in Q3 2026, new ODM contracts and a reduction in inefficient business units.

Media reports from May 2026 said the company plans to expand quarterly capacity at its Cambodian plant to about 230,000 units by Q4 2026. Proceeds from the Georgia plant sale arrived in early September 2026, and the production items of the US subsidiary were moved to the Indonesian plant.

Media reports also say a third plant in Indonesia has begun operating. According to May 2026 coverage, the refund application for US tariffs has been filed with US customs, and cash could take about 60 to 90 days to arrive. Media reported that a value-oriented motion bed set was launched in June 2026.

The next points to track are how quickly US customer orders normalize, whether Cambodian capacity growth offsets lower Indonesian utilization, and how much of the tariff refund and sale gain flows through reported earnings.

07

Valuation

PER
—
PBR
0.3×
ROE
-20.8%
EPS
-₩5,767
BPS
₩24,818
Dividend per share
₩90

Because the company has posted net losses attributable to controlling shareholders over the last four quarters, its price-to-earnings ratio cannot be calculated.

In a loss-making stretch, earnings cannot be compared directly with the company's historical P/E range, and the reference point will shift once earnings recover. The price-to-book ratio sits well below 1x, and market capitalization is far below total equity, which shows the gap.

Continued operating losses and tariff risk are the factors usually cited for a discount to book value. The company continues to pay a dividend even while posting net losses, so the sustainability of that payout depends on earnings recovery and operating cash flow.

Operating cash flow was KRW 216.7 billion in 2025, a sharp change from the outflow in 2024. Total equity of KRW 649.4 billion is about 1.5 times total liabilities of KRW 423.7 billion.

PER, EPS, PBR and BPS are all calculated in-house (the same method as Naver and Toss) · Dividend yield = cash dividend per share from DART filings (supplemented by KRX) ÷ current price · As of 2026-11-13

08

Bull factors

Georgia plant sale eases balance sheet pressure

The Georgia plant sale was agreed at KRW 135.3 billion, and the expected gain of about KRW 31.8 billion was reported after deducting book value of KRW 103.5 billion. Proceeds arrived in early September 2026. Media reports say the borrowing ratio fell from 37.4% at end-2024 to 18.5% in Q3 2026.

Quarterly losses have narrowed

Operating losses narrowed from KRW 30.1 billion in Q1 2026 and KRW 26.7 billion in Q2 to KRW 12.5 billion in Q3. Q3 sales rose 52.7% from Q2, the second straight quarterly increase. The company said customer orders are gradually normalizing and restructuring effects are starting to show.

Financial capacity and production expansion

Total equity at end-2025 was KRW 649.4 billion against total liabilities of KRW 423.7 billion, with a debt-to-equity ratio of 65.3%. Operating cash flow in 2025 was KRW 216.7 billion. Utilization at the Cambodian plant rose to 70.4% in Q1 2026, and capacity expansion is underway.

09

Bear factors

Sharp US sales decline and weak consumer demand

Media reports say US sales in the first half of 2026 fell 48.6% year on year to KRW 191.2 billion. Q3 2026 mattress sales fell 11.7% year on year. With the US above 80% of sales, a delayed demand recovery there would push out any earnings recovery.

Tariffs and falling plant utilization

Because products made in Indonesia face US tariffs, any change in the tariff rate bears directly on profitability. Utilization at the Indonesian plant fell to 51.7% in Q1 2026, raising fixed-cost pressure. Concentrated production in Indonesia leaves the company exposed to tariff changes.

Consecutive losses and higher selling costs

Operating losses have run for five consecutive quarters through Q3 2026, and net losses attributable to controlling shareholders totaled KRW 126.4 billion over the last four quarters. The Q3 selling and administrative expense ratio rose to 32.8% from 29.5% a year earlier. A foreign currency translation loss of KRW 24.8 billion from a weaker currency also weighed on net results.

10

Risk factors

Tariffs and trade policy

If US tariff policy changes while the 19% reciprocal tariff applies to Indonesian mattresses, price competitiveness would be directly affected. The tariff refund application has been filed, but the timing and amount of cash receipt have not been confirmed. The price increase that led to lower orders shows the limits of passing tariff costs on to customers.

Customer concentration and US consumer demand

With the US above 80% of sales, a drop in orders from key customers raises both volume pressure and fixed-cost burden. The steep decline in US sales in the first half of 2026 makes the pace of order recovery critical. High customer concentration adds to earnings volatility.

Currency swings and execution of restructuring

A foreign currency translation loss of KRW 24.8 billion in Q3 2026 shows how exchange-rate moves can swing net results. About KRW 5 billion of one-off severance was booked in selling and administrative expenses during the restructuring.

Early termination of a logistics contract and production transfers are proceeding at the same time, so if the cost savings fall short, the loss period could extend.

11

What to watch next

  1. End of December 2026

    Confirm whether the plan to lift Cambodian quarterly capacity to about 230,000 units is completed in Q4 2026. The key question is how far this offsets lower utilization at the Indonesian plant.

  2. End of March 2027

    The 2026 annual report will show how full-year operating results reflect the tariff refund and the Georgia plant sale gain.

  3. Mid-May 2027

    This is the filing deadline for the Q1 2027 quarterly report. The checks are whether the five-quarter run of operating losses ends and whether sales hold near the Q3 2026 level.

12

Overall view

Zinus returned to operating profit of KRW 25.5 billion in 2025, but it has recorded operating losses for five consecutive quarters through Q3 2026.

Sales fell from KRW 1.16 trillion in 2022 to KRW 913.2 billion in 2025, a decline for three straight years, and with the US above 80% of sales the company is exposed to tariffs and US consumer demand. Net losses attributable to controlling shareholders totaled KRW 126.4 billion over the last four quarters.

On the other side, the Georgia plant sale lowered the borrowing ratio, and Q3 2026 sales rose and operating losses narrowed from Q2. Total equity of KRW 649.4 billion and a debt-to-equity ratio of 65.3% at end-2025 show that financial room remains.

The bull case depends on whether production restructuring and cost cuts show up in earnings, while the bear case is that losses continue if US demand and tariffs do not improve. The next checkpoints are whether operating results move out of losses in the 2026 annual report and the Q1 2027 quarterly report.

13

Sources

  1. Korea Exchange (KRX) — Prices · Market Cap · Volume
  2. FSS electronic disclosure system (DART) — Financial statements · Dividend filings
Show 15 more articles and sources
  1. vegannews.co.kr
  2. topdaily.kr
  3. news.bizwatch.co.kr
  4. boannews.com
  5. hankyung.com
  6. sentv.co.kr
  7. etoday.co.kr
  8. m.news.nate.com
  9. fetv.co.kr
  10. plus.hankyung.com
  11. sentv.co.kr
  12. kbthink.com
  13. huffingtonpost.kr
  14. theguru.co.kr
  15. etoday.co.kr

Report written 2026-11-14 · Data as of 2026-11-13

This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.

Other reports in this industry

View industry analysis